M&A - BIO-RAD LABORATORIES, INC.
Form Type: 8-K
Filing Date: 2025-06-30
Corporate Action: Acquisition
Type: New
Accession Number: 000001220825000032
Filing Summary: On June 30, 2025, Bio-Rad Laboratories, Inc. announced that an affiliate of the company completed the acquisition of all the equity interests of Stilla Technologies, a French corporation. This acquisition follows a binding offer made by Bio-Rad on February 13, 2025, to purchase all of Stilla's equity interests. The details of the acquisition have been outlined, signifying a strategic expansion for Bio-Rad in their operational scope.
Additional details:
Date Of Report: 2025-06-30
Company Name: Stilla Technologies
Acquisition Details: Completed acquisition of all equity interests of Stilla Technologies
Previous Announcement Date: 2025-02-13
Form Type: 8-K
Filing Date: 2025-02-13
Corporate Action: Acquisition
Type: New
Accession Number: 000001220825000004
Filing Summary: On February 13, 2025, Bio-Rad Laboratories, Inc. announced its financial results for the quarter ending December 31, 2024, and disclosed a strategic restructuring plan affecting its U.S. operations. This involves a workforce reduction of approximately 5%, incurring costs between $45 million and $50 million primarily for employee termination benefits. The restructuring is expected to be substantially completed by the end of fiscal year 2025. Additionally, the company has entered into a binding offer to purchase all equity interests in Stilla Technologies, a French corporation, as announced in a press release dated the same day.
Additional details:
Date Of Earliest Event Reported: 2025-02-07
Workforce Reduction Percentage: 5%
Restructuring Cost Estimate Min: 45000000
Restructuring Cost Estimate Max: 50000000
Initial Charge Estimate Min: 30000000
Initial Charge Estimate Max: 35000000
Acquired Company: Stilla Technologies
Acquisition Press Release Date: 2025-02-13
Comments
No comments yet. Be the first to comment!